Faculty highlight: Krystyn Van Vliet
MIT associate professor brings a materials scientist's understanding to biochemical behavior in stem cells and organ tissue.
Finding a needle in a haystack
New technique allows scientists to identify populations of rare stem cells in bone marrow.
Engineering new bone growth
Coated tissue scaffolds help the body grow new bone to repair injuries or congenital defects.
Marrying tissue engineering with systems biology
Linda Griffith combines in vitro models with deep molecular analysis to accelerate drug discovery.
Researchers unlock a new means of growing intestinal stem cells
Studying these cells could lead to new treatments for diseases ranging from gastrointestinal disease to diabetes.
New way to target an old foe: malaria
Engineered liver tissue developed at MIT could help scientists test new drugs and vaccines.
A step closer to artificial livers
Researchers identify compounds that help liver cells grow outside the body.
Tissue engineering: Growing new organs, and more
Research could lead to better ways to heal injuries and develop new drugs.
Precisely engineering 3-D brain tissues
New design technique could enable personalized medicine, studies of brain wiring.
Making ‘nanospinning’ practical
Nanofibers have a dizzying range of possible applications, but they’ve been prohibitively expensive to make. MIT researchers hope to change that.
New injectable gels toughen up after entering the body
These more durable gels could find applications in drug delivery and tissue engineering.
Replicating living structures
Research examines how to control spatial distribution of cells in microenvironments
Merging tissue and electronics
New tissue scaffold could be used for drug development and implantable therapeutic devices.
Success of engineered tissue depends on where it’s grown
Cells grown on different types of scaffolds vary in their ability to help repair damaged blood vessels.
DARPA and NIH to fund ‘human body on a chip’ research
MIT-led team to receive up to $32 million from DARPA and NIH to develop technology that could accelerate pace and efficiency of pharmaceutical testing.